// App-Quantinova.ai

[THU0387] : REFRACTORY SARCOID ARTHRITIS IN WORLD TRADE CENTER- EXPOSED NEW YORK CITY FIREFIGHTERS NECESSITATING ANTI-TNF ALPHA THERAPY

Researchers

Presenter

  • K. Loupasakis

Principal Investigators

  • J. Berman

  • M. Glaser

  • N. Jaber

  • R. Zeig-Owens

  • M. P. Webber

  • M. Weiden

  • A. Nolan

  • K. J. Kelly

  • D. J. Prezant

Medical Centers

  • New York University School of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Rheumatoid arthritis

  • Inflammatory Arthritis

  • Sarcoidosis

Biomarkers

  • 4-hydroxyphenylpyruvate dioxygenase

  • anti-CCP antibodies

  • C reactive protein

  • Estrogen receptor alpha

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved